The effectiveness of short-term psychodynamic psychotherapy in major depressio
Not Applicable
- Conditions
- Major Depressive Disorder.Major depressive disorder, single episode
- Registration Number
- IRCT20230228057566N1
- Lead Sponsor
- Zanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Patients aged 18 to 40 who have been diagnosed with depression
Proficiency in Persian language
If they receive medication, the dose of medication should be fixed
Willingness to treat with a psychodynamic approach
Not receiving other psychotherapy in the last month and during treatment
Ability to fully attend 20 to 40 treatment sessions
Patients' satisfaction and interest in participating in the study
Exclusion Criteria
Existence of bipolar, psychotic, personality and substance abuse disorders
Suicidal tendencies
Physical illness
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of major depressive disorder symptoms. Timepoint: Depression symptoms during the treatment phase and also for comparison with the intervention phase, one month before the treatment (baseline phase) and one month after the end of the treatment (follow-up phase) are evaluated once a week. Method of measurement: beck depression scale, hamilton depression scale.
- Secondary Outcome Measures
Name Time Method Disability due to major depressive disorder. Timepoint: Disability due to major depressive disorder during the treatment phase and also for comparison with the intervention phase is assessed once a month one month before the treatment (baseline phase) and one month after the end of the treatment (follow-up phase). Method of measurement: Sheehan Disability Scale.;Object relation. Timepoint: Object relations during the treatment phase and also for comparison with the intervention phase is assessed once a month one month before the treatment (baseline phase) and one month after the end of the treatment (follow-up phase). Method of measurement: Bell Object Relations and Reality Testing Inventory (BORRTI).